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Abbreviations 
IBD: inflammatory bowel disease 
DCE: dye spraying chromoendoscopy 
VCE: virtual electronic chromoendoscopy 
WLE: white light endoscopy 
HD: high definition  
SD: standard definition 
PPV: positive predictive value 
NPV: negative predictive value 
CI: confidence interval 
 
This study was reported as an oral presentation at the American Gastroenterology 
Association Digestive Diseases Week at San Diego in 2016. 
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Abstract 
 
Background: Dye spraying chromoendoscopy (DCE) is recommended for detection of 
colonic neoplastic lesions in inflammatory bowel disease (IBD). The majority of 
neoplastic lesions are visible endoscopically and therefore targeted biopsies are 
appropriate for surveillance colonoscopy. 
Objective: To compare three different techniques for surveillance colonoscopy to detect 
colonic neoplastic lesions in IBD patients: high definition (HD), (DCE), or virtual 
chromoendoscopy (VCE) using iSCAN image enhanced colonoscopy.  
Methods: A randomized non-inferiority trial was conducted to determine the detection 
rates of neoplastic lesions in IBD patients with longstanding colitis. Patients with inactive 
disease were enrolled into three arms of the study. Endoscopic neoplastic lesions were 
classified by the Paris classification and Kudo pit pattern, then histologically classified by 
the Vienna classification.  
Results: A total of 270 patients (55% men; age range 20–77 years, median age 49 
years) were assessed by HD (n=90), VCE (n=90) or DCE (n=90). Neoplastic lesion 
detection rates in the VCE arm was non-inferior to the DCE arm. HD was non-inferior to 
either DCE or VCE for detection of all neoplastic lesions. In the lesions detected, 
location at right colon and the Kudo pit pattern were predictive of neoplastic lesions {OR 
6.52 (1.98-22.5 and OR 21.50 (8.65-60.10) respectively}.  
Conclusion: In this randomized trial VCE or HD-WLE is not inferior to dye spraying 
colonoscopy for detection of colonic neoplastic lesions during surveillance colonoscopy. 
In fact, in this study HD-WLE alone was sufficient for detection of dysplasia, 
adenocarcinoma or all neoplastic lesions.  
 
 
ClinicalTrials.gov number: NCT02098798 
 
Keywords: colonic lesions, colon cancer, inflammatory bowel disease,  
chromoendoscopy, Kudo pit pattern, Paris classification 
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1. WHAT IS CURRENT KNOWLEDGE 
Dye spraying chromoendoscopy is the recommended method for detection of 
neoplastic lesions in longstanding colonic inflammatory bowel disease.  
The majority of neoplastic lesions are visible endoscopically and therefore 
targeted biopsies are appropriate for surveillance colonoscopy. 
 
2. WHAT IS NEW HERE 
In a randomized trial we could not demonstrate that virtual electronic 
chromoendoscopy or high definition white light colonoscopy was inferior to dye 
spraying colonoscopy. 
Kudo pit pattern and location of lesion in the right colon were predictive of 
neoplastic lesions in surveillance colonoscopy. 
For experienced operators, virtual electronic chromoendoscopy or high definition 
colonoscopy is not inferior to dye spraying colonoscopy for detection of colonic 
neoplastic lesions during surveillance colonoscopy in inflammatory bowel 
disease. However, multicentre, multiple operator studies are required for further 
confirmation.  
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Introduction 
Patients with longstanding inflammatory bowel disease (IBD) have an increased risk of 
developing colorectal cancer, initially estimated to be 18% at 30 years after diagnosis.(1) 
Recent studies reported a decline in incidence of colorectal cancer, which could 
potentially relate to improved control of inflammation and implementation of dysplasia 
surveillance programs.(2)  
 
Surveillance colonoscopy techniques for detection of dysplasia are variable in clinical 
practice. Standard definition white light endoscopy (SD-WLE) with random mucosal 
biopsies has historically been the most common method of IBD surveillance 
colonoscopy, but it is time consuming, expensive, and often poorly adopted in clinical 
practice. (3-6) To increase the detection of neoplastic lesions in patients with IBD, 
targeted biopsies may be the preferred surveillance method compared to random 
biopsies. (7) Studies have shown that dye spraying chromoendoscopy (DCE) with 
targeted biopsies increases the detection rate of neoplastic lesions. (8-10) The new and 
advanced endoscopic technologies have dramatically improved the resolution of images 
compared with previous SD-WLE colonoscopies, so dysplasia has become easier to see 
from the greater image detail.  
 
The recent SCENIC consensus considered DCE the most sensitive modality for 
dysplasia detection in IBD. (6) For example, data to support DCE was provided by 
Marion et al who reported a follow-up evaluation of 68 patients from 2006–2011 with 
longstanding IBD. (11) However, results from a large, retrospective study have shown 
that DCE did not increase dysplasia detection compared with WLE with targeted or 
random biopsies. (12) A prior study using narrow-banding imaging also did not find a 
difference in detection of dysplasia in DCE compared with HD -WLE. (13-15)  
 
New chip technologies have dramatically improved the resolution of image compared 
with previous standard definition colonoscopies. The HD iSCAN (Pentax, Japan) 
technique is a digital electronic chromoendoscopy method. (16-18) We conducted a 
randomized study comparing three different techniques for surveillance colonoscopy to 
detect colonic neoplastic lesions in IBD patients: HD alone, DCE (with HD scopes), and 
VCE using iSCAN digital image enhanced HD colonoscopy. The study was powered for 
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non-inferiority to ascertain if the emerging standard of practice, which is DCE, (6) can be 
replaced by other techniques such as VCE. We also used HD-WLE as a comparator to 
determine whether with improving technology chromoendoscopy is still required. We 
also aimed to identify the specific clinical and endoscopic features of colonic lesions that 
were predictors of dysplasia in IBD.  
 
Patients and Methods  
This was a randomised prospective trial conducted at a single large tertiary referral 
centre at the University of Calgary.  
 
The Calgary Conjoint Health Services Research Ethics Board of the University of 
Calgary (CHREB) approved the study. The study was registered at ClinicalTrials.gov 
with identification number: NCT02098798.  
 
IBD patients referred for surveillance colonoscopy were enrolled after they provided 
informed consent between March 2014 and March 2016.  
 
The primary outcome of the study was to compare the detection rates of colonic 
neoplastic lesions in longstanding UC or CD with HD + DCE versus HD + VCE. 
Secondary outcomes included comparison of detection rates of neoplastic lesions in 
longstanding UC or CD with HD alone versus HD +DCE and HD alone versus HD+VCE.  
 
A further study goal included characterization of endoscopic features of neoplastic  
colonic lesions detected for  prediction of dysplasia . The inclusion criteria were 
extensive or left sided ulcerative colitis, colonic Crohn‘s disease, or unclassified colitis 
involving at least one third of the colonic mucosa (i.e. ileocecal disease alone were not 
included and these patients did not undergo surveillance in our centre), duration of the 
disease >8 years, or any duration in patients with concomitant diagnosis of primary 
sclerosing cholangitis, who could enter surveillance irrespective of disease duration. 
Clinical and endoscopic remission with Mayo total score <3, and a Mayo endoscopic 
subscore of 1 or 0 (overall Mayo endoscopic score and no segment of colon had Mayo 
endoscopic score >1), or Harvey-Bradshaw Index (HBI) <5 and Simple Endoscopic 
Score of Crohn’s disease of ≤4. (19,20)  
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Patients were excluded if they were pregnant, had active inflammatory disease, did not 
have optimal bowel preparation, had coagulopathy, had a known allergy to dye spray, or 
were unable to provide informed consent.  
 
All patients enrolled were randomly allocated in blocks of four and assigned at a 1:1:1 
ratio to undergo colonoscopy with high definition WLE (HD-WLE, group A), high 
definition DCE (HD-DCE, group B), or high definition VCE (HD-VCE, group C) using a 
computer generated allocation. The randomization was assigned before the colonoscopy 
by an independent coordinator blinded to the patients’ history. The patients were 
randomized consecutively without stratification by presence or absence of primary 
sclerosing cholangitis, family history, or by gender. The different groups of surveillance 
patients according to surveillance methods are shown in Table 1. A flow diagram of the 
study is shown in Figure 1. 
 
Endoscopic assessment  
The colonoscopies were performed by a single operator (MI) experienced in dye, optical, 
and digital electronic virtual chromoendoscopy and colonic lesions characterization. This 
ensured uniform application of technique and uniform cognitive skills. The histology was 
assessed by XG, SU, and PM, who were blinded to the endoscopic reports. All the 
endoscopic procedures were performed using HD+ iSCAN Pentax EC-3490Fi with EPKi 
7000 (Pentax, Japan) video processor. The system consists of three types of algorithms: 
Surface Enhancement iSCAN 1 (SE) for detection of abnormalities and lesions in the 
gastrointestinal tract, and Tone Enhancement (TE) and Contrast Enhancement (CE) 
iSCAN 2 and 3, for pattern and vascular characterization. Each of these algorithm sets 
could be selected by pressing a pre-assigned button on the hand-piece of the scope. 
(17,18)  
Quality of bowel preparation was graded using the Ottawa bowel preparation scale 
defined as excellent, good, fair, poor and inadequate. (22) Only patients with excellent or 
good bowel preparation were included in the study. Endoscopic activity of the disease 
was assessed using the Mayo endoscopic subscore for ulcerative colitis (19) and Simple 
Endoscopic Score for Crohn’s disease activity.(21) The colonoscope was advanced to 
the cecum and the colonic mucosa was meticulously washed with the water jet pump. 
On withdrawal, each segment (cecum, ascending colon, transverse colon, descending-
sigmoid, and rectum) was sequentially examined for lesions using HD endoscopic 
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technique for group A, DCE using 0.04% methylene blue or 0.03% of indigo carmine for 
group B, and virtual chromoendoscopy (VCE) in the iSCAN 2 and 3 mode for group C. 
We detected and characterized lesions on withdrawal after dye spraying or after turning on 
iSCAN or with HD-WLE. We did not focus on detection at insertion of the colonoscope, a 
protocol similar to the Kiesslich et al. study (8). 
The time to withdraw from the cecum to the rectum was measured in each patient in all 
the different groups.  
 
Biopsy protocol  
Mucosal abnormalities were recorded in each group with regard to location (distance 
from the anus in centimetres), morphology (polypoid or non-polypoid), and size using the 
Paris classification.(24) For each lesion, the mucosal pit pattern was characterized using 
the Kudo pit pattern.(25) On withdrawal of the colonoscope, targeted biopsy specimens 
or endoscopic resection specimen from targeted suspicious areas of dysplasia 
(circumscribed lesions with irregular surface) were obtained. When the colonic lesion 
was endoscopically resectable, cautery snare polypectomy or endoscopic mucosal 
resection was performed, and a few histological samples were taken from the 
perilesional surrounding mucosa to rule out any multifocal dysplasia. Biopsies were 
taken to assess inflammatory activity. 
 
Endoscopic characterisation of the colonic lesions  
Endoscopic colonic lesions were classified by the Kudo pit pattern and the Paris 
classification, (24,25) and histology was characterized by the Vienna classification 
(consensus amongst pathologists). Lesions were classified as polypoid and non-
polypoid dysplastic lesions, adenocarcinoma, sessile serrated adenomas/, and tubular 
adenoma in non-colitic areas.  
 
Histopathologic evaluation 
Inflammatory activity in samples of each specimen container was classified into the 
following categories based on pathology: no inflammation, mild to moderate 
inflammation, or severe inflammation.(26) Neoplastic changes were classified with the 
new modified Vienna classification into hyperplasia, low-grade dysplasia, high-grade 
dysplasia, or adenocarcinoma in the colitic areas (Table 2). Areas that were suspicious 
 9 
for neoplasia were sent to a second or third experienced pathologist for further review 
(27). 
 
Statistical analysis  
The study was powered for non-inferiority with a one-way threshold difference of rates of 
10% in detection of all neoplastic lesions between DCE and VCE arms and assuming a 
detection rate of 20% for all neoplastic lesions (10% for dysplastic lesions and 
adenocarcinoma) requiring a sample size of 90 patients in each group for 1-tail p<0.025 
with 80% power. The assumption rates for detection of all neoplastic lesions was based 
on previous publications (6,7,8,11,28,31).  
 
Quantitative variables were expressed as means ± SDs. Categorical variables were 
expressed as total number and frequencies (%). Quantitative variables were analyzed 
using Fisher’s Exact test. The data were analysed for the most significant lesions 
(dysplasia polypoid or non-polypoid or adenocarcinoma) or for all neoplastic lesions 
(sessile serrated adenoma, tubular adenoma in non-colitic areas, dysplasia, or 
adenocarcinoma): p values less than 0.05 were considered statistically significant.  
 Exploratory univariate logistic regression analysis was performed for selecting 
endoscopic variables associated with the presence of dysplasia or cancer. Those 
features that were significant at the univariate stage were included in a multivariate 
logistic regression.  We included ORs with 95% CIs to quantify the association of the 
endoscopic findings with dysplasia/cancer  
 Finally, estimates of predictive accuracy were attained using a bootstrapping technique. 
Training data was derived by randomly sampling from the observations with 
replacement. The test data were the observations not used for training. This process 
was done 500 times, to get estimates of standard error about the validity measures. The 
multivariate model was fit for each iteration of the bootstrap and predictions were made 
for the test data. This allows for the estimates of accuracy, sensitivity, specificity, PPV, 
and NPV and accuracy for characterization of colonic lesions were calculated for 
patients in each arm of the surveillance groups, with histology as the gold standard. 
The analysis was “per protocol” and statistical analysis was performed using the 
statistical software package SPSS 23.0 (IBM, USA).  
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Results  
Demographics characteristics of the patients  
A total of 285 consecutive patients with longstanding IBD who consented to study 
participation underwent surveillance colonoscopy between March 2014 and March 2016. 
Fifteen patients were excluded because they did not meet the inclusion criteria due to 
insufficient bowel preparation or active inflammation (Figure 1). The demographic details 
of the patients are summarized in Table 1. 
 
A total of 270 patients (55% men; age range 20–77 years, median age 49 years) fulfilled 
the inclusion criteria and were enrolled in the trial (48% ulcerative colitis, 50.3% Crohn’s 
disease, 1.8% unclassified colitis). The disease duration ranged from 2 to 46 years 
(median disease duration 14.5 years).Twenty-nine (10.7%) patients had a family history 
of colon cancer and 60 (22.2%) had a personal history of colonic lesions diagnosed at 
previous colonoscopies (Table 1). No patients in the study had adverse events such as 
bleeding, perforation, or death. 
 
Colonic neoplasia detection rates among the different endoscopic procedures 
group 
Out of the 270 patients, 90 patients were enrolled in the HD arm, 90 patients in the DCE 
arm, and 90 patients in the VCE arm. In the study, 33 sessile serrated adenomas were 
found in 21 patients (7.7% of patients), 9 tubular adenoma were found in 5 patients in 
non-colitic areas (1.9% of patients), 49 dysplastic lesions (41 were polypoid and 8 were 
non-polypoid) were found in 39 patients (14.4% of patients), and adenocarcinoma was 
found in one patient (0.3% of patients). The colonic neoplastic lesions found in each 
surveillance arm and in each patient cohort are detailed in Tables 2 and 3. 
 
The primary outcome of VCE was non-inferior to DCE for detection of dysplasia and 
adenocarcinoma and for all lesions (Fisher’s Exact p=1 and 0.64); 95% confidence limits 
of the rate difference for all lesions was -0.17 to 0.08 establishing non-inferiority of VCE 
compared with DCE (one-way difference not crossing the pre-specified non-inferiority 
threshold of 0.1 ie. 10%).  HD was non-inferior to DCE for detection of dysplasia and 
adenocarcinoma and for all lesions (Fisher’s Exact p=0.65 and 0.71); 95% confidence 
limits of the rate difference for all lesions was -0.29 to 0.02 establishing non-inferiority of 
HD compared with DCE (one-way difference not crossing the non-inferiority threshold of 
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0.1 ie.10%). HD was non-inferior to VCE for detection of dysplasia and adenocarcinoma 
and for all lesions (Fisher Exact p=1 and 0.58); 95% confidence limits of the rate 
difference for all lesions was -0.34 to 0.07 establishing non-inferiority of HD compared 
with VCE (one-way difference not crossing the non-inferiority threshold of 0.1 ie 10%).  
Dysplasia (polypoid and non-polypoid) and adenocarcinoma detection rates were similar 
among the three arms of the study (p=0.84) (Table 2). Non-polypoid dysplasia detection 
rates were similar in all three groups, but the numbers were small. All lesions, including 
sessile serrated adenoma, tubular adenoma in non-colitic areas, dysplasia, and 
adenocarcinoma detection rates were similar among the three arms of the study 
(p=0.74).  
 
When analysed by number of patients with dysplasia (polypoid and non-polypoid) and 
adenocarcinoma (Table 3), the three arms were similar (p=0.91). When analysed by 
number of patients with all lesions, including sessile serrated adenoma, tubular 
adenoma in non-colitic areas, dysplasia, and adenocarcinoma, the three arms were 
similar (p=0.99). VCE was not inferior to DCE in the number of lesions detected (Table 
3). 
 
In the DCE group the first 18 consecutive patients enrolled underwent colonoscopy with 
0.04% indigo carmine and the remaining 72 patients with 0.03% methylene blue 
because the indigo carmine ampules stopped being available in North America. 
 
Regarding characterization of lesions, the three techniques had similar sensitivity and 
specificity to predict histology of colonic lesions (neoplastic versus non-neoplastic; 
neoplastic included dysplasia, carcinoma, adenoma, and sessile serrated adenoma and 
non-neoplastic included pseudopolyps and hyperplastic). The sensitivity, specificity, 
PPV, NPV and accuracy of each technique to predict histological determination of 
neoplastic lesions were determined. HD had a sensitivity of 91.3%, specificity of 78.1%, 
PPV 88.2%, NPV 88.2%, and accuracy 86%. DCE had a sensitivity of 84.6%, specificity 
of 79.5%, PPV 70.9%, NPV 88.2%, accuracy 81.4%, and VCE had a sensitivity of 
92.3%, specificity of 62.5 %, PPV 73 %, NPV 88.2%, and accuracy 78%. 
 
Procedure duration in the different arms of the study  
The duration of the withdrawal time of colonoscopy in minutes for patients in the HD 
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group was median 15.4 (range 10–22 min), in the DCE was median 16.2 (range 12–35 
min), and in the VCE was median 15.3 (range 9–26 min). The 3-way Kruskal-Wallis 
Rank Sum non-parametric test was used to compare the 3 groups (p=NS). Random 
biopsies were not used (apart from inflammation assessment), which reduced 
withdrawal time.  
 
Clinical and endoscopic predictors of dysplasia  
The endoscopic morphologic characteristics and distribution of the lesions are shown in 
Appendix 1. Among 270 patients, 91 colonic dysplastic lesions and 1 adenocarcinoma 
were found. Sixty-two were polypoid and 29 were non- polypoid. Most of these lesions 
(92.3%) had the Kudo pit pattern III-V types.  
 
 
Results of univariate and multivariate logistic regression analysis  
In the univariate analysis, the following were all associated with correct prediction of 
colonic neoplasia for all the lesions detected: age in years had an odds ratio (OR) of 
1.05 (95% CI 1.02–1.08), localization of the lesions in the right colon had an OR of 6.15 
(95% CI 3.12–12.12), Kudo pit pattern types IIO, III-IV, and V had an OR of 20.91 (95% 
CI 9.34–46.7), and Paris Is/Ip classification had an OR of 3.29 (95% CI 1.69–6.38) 
(Table 4). Proportional multivariate logistic regression model for the prediction of colonic 
neoplasia was performed for all detected lesions. Endoscopic Kudo pit pattern (OR 
21.50; 95% CI 86.5–60.1) and localization of the lesions in the right colon (OR 6.52; 95% 
CI 1.98–22.5) were strong predictors of colonic neoplasia (Table 5). When we combined 
these independent variables of predictors of neoplastic histological changes in detected 
lesions, the overall accuracy was 78% (95% CI 68–88%), sensitivity 82% (95% CI 68–
97%), specificity 68% (95% CI 47–89%), PPV 85% (95% CI 76–95%), and NPV 64% 
(95% CI 42–86%) when referenced against the histology of these detected lesions (the 
gold standard).  
 
 
Discussion  
In our randomised trial we did not demonstrate a statistical difference between HD, VCE, 
and DCE in the detection rate of colonic dysplastic lesions in IBD patients. We have 
demonstrated that the neoplasia detection rate of targeted biopsies was similar among 
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the three arms of the study: HD, DCE, and VCE. Our detection rates of neoplastic 
lesions were similar to other studies conducted for detection rates during surveillance in 
IBD. (6) The results were similar when sessile serrated adenoma lesions were not 
considered. Therefore in this study, the finding support use of HD-WLE for IBD 
surveillance but multicentre, multi-observer studies are required to confirm these 
findings. 
 
In a retrospective observational study, Subramanian et al also found that dysplasia was 
discovered in approximately twice the number of patients undergoing HD colonoscopy 
compared with SD-WLE colonoscopy: the adjusted prevalence ratio was 2.2 (95% CI 
1.1–4.5). (28)  
 
DCE is considered the standard of the care to increase detection rate of neoplasia in 
IBD patients. A recent meta-analysis of eight studies, which used the previous 
generation of SD-WLE endoscopes, revealed that DCE compared to SD-WLE 
significantly increased the number of dysplastic lesions detected by almost 2-fold 
(RR=1.9; 95% CI 1.4–2.7). (6) 
 
Mooiweer et al demonstrated that implementation of DCE for IBD surveillance in clinical 
practice did not increase dysplasia detection compared with WLE with targeted and 
random biopsies in a large “real-life” cohort. (12) It is possible that with improvement in 
resolution of images in endoscopy and expertise in optical diagnosis, the advantage of 
DCE becomes less apparent, at least for expert operators.  
 
There is still confusion and debate regarding whether DCE should be adopted by every 
endoscopist doing surveillance in IBD. (29) There are also many unanswered questions 
despite SCENIC guidelines. (29) Unfortunately, there are limited prospective studies 
comparing DCE with currently used advanced technologies such as HD-WLE and VCE. 
The latest generation of colonoscopes have dramatically improved the brightness and 
sharpness of the quality of images, which has increased detection and characterisation 
of dysplasia more apparent. This has enabled greater prediction of the histological 
nature of the dysplasia, improving the definition of margins and feasibility of local 
endoscopic resection versus colectomy. These developments have the potential to 
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increase local resection based on characterisation rather than on pan-
proctocolectomy.(16-18) 
 
Previous randomised studies comparing narrow band imaging to HD-WLE colonoscopy 
have not suggested a benefit for narrow band imaging to detect more dysplasia in IBD 
patients. (6,13-15) The new generation of electronic chromoendoscopes are however 
getting better in brightness and contrast. To our knowledge this is the first study utilizing 
the new generation of iSCAN virtual chromoendoscopy in surveillance IBD patients. We 
also need to clarify whether DCE can be performed in the community setting or only in 
IBD centres with expert, dedicated IBD endoscopists. The study by Pelise et al 
suggested that DCE could be adopted widely for IBD surveillance. (30,31) Similarly we 
need to determine via multi-operator multicentre studies whether this is also true for HD-
WLE (and VCE). 
  
We have used targeted biopsies based on the evidence of previous literature and 
European Society of Gastrointestinal Endoscopy guidelines. (32-34) Studies have 
demonstrated that only one in a thousand random biopsies revealed dysplasia and only 
about 1% to 1.5% of all patients undergoing surveillance would not have dysplasia 
detected if random biopsies were not performed. Spanish centres have reported similar 
findings following targeted biopsies in the setting of real life practice. (31) Our previous 
report of a cohort of 450 IBD patients undergoing surveillance colonoscopy supports the 
view that targeted biopsy is the preferred surveillance method compared to random 
biopsies to increase the detection of neoplastic lesions in patients with IBD. (35) This 
study had suggested that targeted biopsies alone may be sufficient for HD-WLE, DCE, 
and VCE but not for SD-WLE. (35) Also in SCENIC’s recent statement of replacing 
random by targeted biopsies, 85% of the panellists had agreed. (6) Note that SD-WLE 
may still require random biopsies, even if targeted biopsies alone may be sufficient for 
HD-WLE, DCE, and VCE, apart from a few biopsies to assess inflammatory status. In 
our study, patients with active inflammation in any colonic segment were not included in 
the study. Therefore, in our clinical practice we preferred to perform surveillance 
colonoscopy in IBD patients using targeted biopsies.  
 
In our study, exploratory univariate and multivariate statistical model analysis of the 
colonic lesions detected and characterised by the three technologies were performed to 
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predict clinical or endoscopic features predictive of colonic neoplasia in IBD patients 
(histology gold standard). The endoscopic Kudo pit pattern and localisation of the lesions 
in the right colon were predictors of colonic neoplasia in IBD (Tables 4 and 5). Sensitivity 
analysis by excluding sessile serrated adenoma lesions did not change the conclusions. 
Family history of colorectal cancer was not a predictor of the colorectal neoplasia.  
 
The value of Kudo pit patterns to predict histology in IBD patients remains controversial 
especially when these lesions are assessed by using standard scopes without 
magnification. The colonic mucosa of IBD patients might be distorted due to 
longstanding chronic inflammation; furthermore, dye spraying may also obscure the 
Kudo pit pattern. The Kudo pit pattern can be assessed with the new generation HD with 
or without virtual chromoendoscopy and without magnification, as in this study. (33,35) 
Though not the primary objective of this study, we do present our data in the context of 
this study on lesion characterisation, including the Kudo pit pattern. This is the first 
support for using the Kudo pit pattern in neoplastic lesions characterisation in IBD 
surveillance. Further studies are required on lesion characterisation including usefulness 
of the Kudo pit pattern in the context of IBD. 
 
In our study, there were a disproportionate number of primary sclerosing cholangitis 
patients in the HD group, as recruitment was not stratified. However, only one low grade 
dysplastic lesion was detected in a patient with UC associated primary sclerosing 
cholangitis who underwent surveillance in the VCE group. Analysing the results by 
excluding primary sclerosing cholangitis patients did not change the conclusions, with 
the limitation that it reduced the sample size in each arm. As only one low grade 
dysplastic lesion was detected in a patient with UC associated primary sclerosing 
cholangitis who underwent surveillance in the VCE group, the PSC-IBD group did not 
impact the results of this study but we had included these PSC patients as this is an 
important surveillance group.  
 
 
A strength of our study is that it has been prospectively performed in a randomized 
fashion by an expert endoscopist trained on advanced technologies and IBD, as in 
procedural randomization, standardizing skills, learning curve, and experience may be 
confounding factors with multiple endoscopists. Having one expert endoscopist 
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harmonised the cognitive elements of lesion detection and characterization. Performing 
a three arm randomized study with back to back colonoscopies in a multi-operator, 
multicenter format is challenging and we hope our study will help plan further studies by 
choosing two rather than three techniques. We hope both single observer and multi 
observer studies will inform the debate as this is the second randomized study 
comparing different techniques for surveillance colonoscopy in IBD. The operator (MI) 
had considerable experience with all three techniques, and the analysis of the data over 
quartiles of procedures did not show any increase in detection rates. Other studies such 
as recent study of mucosal healing endoscopic Mayo score 0 Vs 1 also involved a single 
experienced operator, Barreiro-de Acosta, who did all the endoscopies (36), to 
minimised the risk of inter-observer variability in assessment. More importantly, the 
pivotal paper on dye chromoendoscopy was done by a single operator, Dr M Rutter (37), 
However, we also acknowledge that this is also a limitation (e.g. would other operators 
see similar results?) and therefore multiple operators are recommended for future 
randomized trials. Additionally, in future multicentre studies, skills and learning curve 
with the three techniques should be harmonised by training modules to achieve 
acceptable inter-observer agreement or by central readout. This should also involve 
different endoscopy platforms such as iSCAN (Pentax), NBI (Olympus) and BLI 
(Fujinon), but because of rapid advances in technology needs harmonized skills and 
latest generation scopes and processors. The three arm single operator study should be 
followed up by a two arm multicentre study with multiple operators and from the results 
of our study it would be rational to use HD-WLE and DCE. 
 
Kiesslich et al. in the pivotal randomized trial establishing the use of methylene blue dye 
spraying chromoendoscopy used 1:1 randomization and not tandem colonoscopies (8); 
we followed a similar protocol in a 1:1:1 randomization as it is difficult to do tandem 
studies with a three- arm design and patient acceptance of tandem colonoscopy may be 
limited. Similar to our study, the randomized dye Chromoendoscopy versus white light 
Chromoendoscopy trial by Kiesslich et al. (8) the lesions were only detected on 
withdrawal.   
Stratification by primary sclerosing cholangitis or family history may also be relevant in 
future studies, although sensitivity analysis without these patients did not change the 
conclusion. Neither primary sclerosing cholangitis nor family history predicted neoplasia 
in multivariate analysis. There was no apparent difference between ulcerative colitis and 
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Crohn’s colitis in detection rates, although the study was not powered to answer this 
question. 
 
In conclusion, our randomized trial demonstrated that for experienced operators, virtual 
electronic chromoendoscopy or high definition colonoscopy is not inferior to dye spraying 
colonoscopy for detection of colonic neoplastic lesions during surveillance colonoscopy. 
In fact, in this study HD colonoscopy alone was sufficient for detection of dysplasia, 
adenocarcinoma or all neoplastic lesions. However, multicentre, multiple operator 
studies are required verify our conclusions.  
 
 
 
 
Table 1. Characteristics by surveillance group. 
 
Table 2. Colonic lesions found in each surveillance group: histological evaluation as 
modified by the Vienna classification. 
 
Table 3. Number of patients with neoplastic lesions found in each surveillance group. 
 
Table 4. Univariate analysis: endoscopic findings predictive of dysplasia. 
 
Table 5. Multivariate analysis: endoscopic findings predictive of dysplasia. 
 
 
 
Figure 1. Patients recruited in the study. 
 
Figure 2. Polypoid lesion with low grade dysplasia: (a-b) High definition showed sessile 
lesion, Paris classification Is with areas of Kudo pit pattern II-IV and definite margins; (c-
d) polypoid lesion with low grade dysplasia assessed by virtual electronic 
chromoendoscopy and Kudo pit pattern IIIL-IV. 
 
Figure 3. Non polypoid lesion: (a) high definition showed a flat lesions, Paris 
classification IIb with definite margins; (b) dye spraying chromoendoscopy with 
methylene blue 0.03%. 
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